Breast cancer susceptibility gene mRNAs quantified by microarrays with electrochemical detection

Clinical Chemistry

Volumn 50, Issue 7, 2004, Pages 1231-1233

  Xie, Hong ^a   Yu, Yuan Hong ^a   Xie, Fang ^a   Lao, Yuan Zhi ^a   Gao, Zhiqiang ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; BIOSENSOR; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ELECTROCHEMICAL DETECTION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MEASUREMENT; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RNA EXTRACTION;

BIOSENSING TECHNIQUES; BREAST NEOPLASMS; ELECTROCHEMISTRY; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 3042569517     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.031559     Document Type: Article

References (15)

1. Watson J, Gilman M, Witkowski J, Zoller, M. Recombinant DNA, 2nd ed. New York: W.H. Freeman and Company, 1992:127-30.
2. Chan SDH, Dill K, Blomdahl J, Wada HG. Nonisotopic quantification of mRNA using a novel RNase protection assay: measurement of erbB-2 mRNA in tumor cell lines. Anal Biochem 1996;242:214-20.
3. Cottrez F, Auriault C, Capron A, Groux H. Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res 1994;22:2712-3.
4. TotzeG, Sachinidis A, Vettre H, Ko Y. Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression. Mol Cell Probes 1996;10:427-33.
5. Baugh R, Hill AA, Brown EL, Hunter CP. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 2001;29:e29.
6. Zhang Y, Kim HH, Heller A. Enzyme-amplified amperometric detection of 3000 copies of DNA in a 10-μl droplet at 0.5 fM concentration. Anal Chem 2003;75:3267-9.
7. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan C-P, Zhang XH, et al. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 2000;60:2232-8.
8. Hoevel T, Holz H, Kubbies M. Cisplatin-digoxigenin mRNA labeling for nonradioactive detection of mRNA hybridized onto nucleic acid cDNA arrays. Biotechniques 1999;27:1064-7.
9. Xie H, Zhang CY, Gao ZQ. Amperometric detection of nucleic acid at femtomolar levels with a nucleic acid/electrochemical activator bilayer on gold electrode. Anal Chem 2004;76:1611-7.
10. Gao ZQ, Binyamin G, Kim HH, Barton SC, Zhang YC, Heller A. Electrodeposition of redox polymers and codeposition of enzymes by coordinative crosslinking. Angew Chem Int Ed 2002;41:810-3.
11. Gullans SR. Of microarrays and meandering data points. Nat Genet 2000;26:4-5.
12. Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003;196:19-41.
13. Pavelic K, Gall-Troselj K. Recent advances in molecular genetics of breast cancer. J Mol Med 2001;79:566-73.
14. Saad Z, Bramwell VH, Wilson SM, O'Malley FP, Jeacock J, Chambers AF. Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Lancet 1998;351:1170-3.
15. Ausubel FM, Brent R, Kingston RE, More DD, Seidman JG, Smith JA, eds. Current protocols in molecular biology. New York: Wiley, 1987:4.7.1.-4.7.8.